Correction: Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand

被引：0
|
作者：
Junhui Yu
Kui Yang
Jianbao Zheng
Wei Zhao
Xuejun Sun
机构：
[1] First Affiliated Hospital of Xi’an Jiaotong University,Department of General Surgery
来源：
Cancer Gene Therapy | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：871 / 872
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
    Mudaliar, Sunder
    Henry, Robert R.
    Sanyal, Arun J.
    Morrow, Linda
    Marschall, Hanns-Ulrich
    Kipnes, Mark
    Adorini, Luciano
    Sciacca, Cathi I.
    Clopton, Paul
    Castelloe, Erin
    Dillon, Paul
    Pruzanski, Mark
    Shapiro, David
    GASTROENTEROLOGY, 2013, 145 (03) : 574 - +
  • [32] Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model
    Comeglio, P.
    Filippi, S.
    Sarchielli, E.
    Morelli, A.
    Cellai, I.
    Corno, C.
    Adorini, L.
    Vannelli, G. B.
    Maggi, M.
    Vignozzi, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (08) : 951 - 965
  • [33] Inactivation of Adenomatous Polyposis Coli Reduces Bile Acid/Farnesoid X Receptor Expression through Fxr gene CpG Methylation in Mouse Colon Tumors and Human Colon Cancer Cells
    Selmin, Ornella I.
    Fang, Changming
    Lyon, Adam M.
    Doetschman, Tom C.
    Thompson, Patricia A.
    Martinez, Jesse D.
    Smith, Jeffrey W.
    Lance, Peter M.
    Romagnolo, Donato F.
    JOURNAL OF NUTRITION, 2016, 146 (02): : 236 - 242
  • [34] Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms
    Guo, Cen
    LaCerte, Carl
    Edwards, Jeffrey E.
    Brouwer, Kenneth R.
    Brouwer, Kim L. R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 365 (02): : 413 - 421
  • [35] Differential roles of farnesoid X receptor (FXR) in modulating apoptosis in cancer cells
    Girisa, Sosmitha
    Rana, Varsha
    Parama, Dey
    Dutta, Uma
    Kunnumakkara, Ajaikumar B.
    APOPTOSIS IN HEALTH AND DISEASE, PT B, 2021, 126 : 63 - 90
  • [36] Evidence that Farnesoid X Receptor ligand through SF-1 responsive element inhibits aromatase expression in Leydig tumor cells
    Ando, Sebastiano
    Malivindi, Rocco
    Rizza, Pietro
    Gu, Guowei
    Panza, Salvatore
    Catalano, Stefania
    FASEB JOURNAL, 2009, 23
  • [37] Suppression of Lung Oxidative Stress, Inflammation, and Fibrosis following Nitrogen Mustard Exposure by the Selective Farnesoid X Receptor Agonist Obeticholic Acid
    Meshanni, Jaclynn A.
    Lee, Jordan M.
    Vayas, Kinal N.
    Sun, Rachel
    Jiang, Chenghui
    Guo, Grace L.
    Gow, Andrew J.
    Laskin, Jeffrey D.
    Laskin, Debra L.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2024, 388 (02): : 586 - 595
  • [38] A PRELIMINARY STUDY OF THE EFFECTS OF OBETICHOLIC ACID, A FARNESOID X RECEPTOR AGONIST, IN PATIENTS WITH CHRONIC DIARRHOEA SECONDARY TO CROHN'S ILEAL DISEASE
    Nolan, J. D.
    Vassie, C.
    Johnston, I. M.
    Shapiro, D.
    Walters, J. R.
    GUT, 2014, 63 : A258 - A258
  • [39] THE FIRST NEW MONOTHERAPY THERAPEUTIC PBC STUDY IN A DECADE? AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID IN PBC
    Jones, D.
    Kowdley, K.
    Chapman, R.
    Burroughs, A.
    Hirschfield, G.
    Schramm, C.
    Poupon, R.
    ParEs, A.
    Shapiro, D.
    Pruzanski, M.
    GUT, 2011, 60 : A50 - A50
  • [40] Inhibition of autophagy increases tumor-specific synergistic cytotoxicity between oxaliplatin and roscovitine in colon cancer cells
    Qiao, Na
    Keyomarsi, Khandan
    Hunt, Kelly
    Meijer, Laurent
    Lambert, Donald
    Lambert, Laura
    CANCER RESEARCH, 2009, 69
12345